-1.53%
Today
Loading 1D prices…
Company profile
InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Herzliya, Israel, United States
Employees
285
Fiscal year end
1231
CIK
1857030
Session & valuation
Latest annual period
Deterministic peer set
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| IBIOiBio Inc. Common Stock | $77.5M | $100K | -33044.00% | -$0.32 | -0.38% | Buy |
| LFVNLifevantage Corporation Common Stock (Delaware) | $77.3M | $182.6M | +2.78% | $0.40 | -3.61% | Hold |
| GANXGain Therapeutics Inc. Common Stock | $76.4M | $0.00 | — | -$0.61 | +2.34% | Buy |
| OSTXOS Therapies Incorporated Common Stock | $78.6M | $0.00 | — | -$0.98 | -7.69% | Buy |
| MAIAMAIA Biotechnology Inc. Common Stock | $79.1M | $0.00 | — | -$0.70 | -1.53% | Buy |